Showing results (111-120 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|September 1, 1996
Calcium antagonists and endothelial function: focus on nitric oxide and endothelinT Godfraind, S SalomoneCardiovascular Drugs and Therapy|July 1, 1996
Renin inhibitors: cardiovascular drugs of the future?J M Wood, P CloseCardiovascular Drugs and Therapy|November 1, 1996
Emerging concepts: angiotensin-converting enzyme inhibition in coronary artery diseaseG B ManciniCardiovascular Drugs and Therapy|May 20, 2015
Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic FactorsAgata Bryk, Ewa Wypasek, Magdalena Awsiuk, et al.Cardiovascular Drugs and Therapy|October 19, 2010
Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPOTakahiro Sato, Masaya Tanno, Takayuki Miki, et al.Cardiovascular Drugs and Therapy|September 17, 2009
How can we improve the management of vascular risk in type 2 diabetes: insights from FIELDGeorge SteinerCardiovascular Drugs and Therapy|August 1, 1990
Ischemia, reperfusion, and the determinants of tissue injuryD J HearseCardiovascular Drugs and Therapy|August 1, 1990
Perioperative assessment of the quality of myocardial protectionJ N Fabiani, V Jebara, A CarpentierCardiovascular Drugs and Therapy|August 1, 1990
A new semiautomated algorithm to quantify Holter-detected myocardial ischemia: preliminary experience in the Trimetazidine European Multicenter trial (TEMS)J M Detry, R Fesler, T Berckmans, et al.Pageof 302